|4Feb 8, 7:38 PM ET

FASOLA KENNETH J 4

4 · CENTENE CORP · Filed Feb 8, 2024

Insider Transaction Report

Form 4
Period: 2024-02-07
FASOLA KENNETH J
EVP, Health Care Enterprises
Transactions
  • Sale

    Common Stock

    2024-02-07$74.83/sh8,190$612,858239,175 total
  • Sale

    Common Stock

    2024-02-07$75.58/sh3,810$287,960235,365 total
Holdings
  • Phantom Stock

    Exercise: $0.00From: 2023-03-10Exp: 2023-03-10Common Stock (3,605.628 underlying)
    3,605.628
Footnotes (5)
  • [F1]The weighted average price for this transaction is reported within the form. Shares were sold at prices ranging from $74.43 to $75.39. Full information regarding the number of shares at each price is available upon request.
  • [F2]The weighted average price for this transaction is reported within the form. Shares were sold at prices ranging from $75.44 to $75.81. Full information regarding the number of shares at each price is available upon request.
  • [F3]Ownership includes 180,027 shares of restricted stock subject to vesting requirements.
  • [F4]Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock.
  • [F5]The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect.

Documents

1 file
  • 4
    wk-form4_1707439111.xmlPrimary

    FORM 4